Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

New diagnostic method replaces surgery for bowel tumor assessment

A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.

19 Mar 2015

Genetic markers may help decide who benefits from aspirin, NSAIDs in lowering risk of colorectal cancer

An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.

18 Mar 2015

Penn researchers find evidence of new culprit in colon cancer

Colon cancer is a heavily studied disease -- and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010.

17 Mar 2015

Parenchymal preservation surgery linked to lower mortality, complication rates in cancer patients

A surgical approach in which a surgeon removes less than a lobe of the liver in a patient undergoing an operation for liver cancer is associated with lower mortality and complication rates, according to new study results published online as an "article in press" in the Journal of the American College of Surgeons (JACS).

13 Mar 2015

TNMNews examines how cannabis laws impact students, families

The latest segment of TNMNews, the unbiased marijuana talk radio program from DigiPath, Inc., focuses on how laws based on the War on Drugs have hurt students and families.

13 Mar 2015

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

Kalorama Information estimated the budding market for digital PCR reached 175 million in 2014. The market research publisher said companies will be looking to provide products to increase research and diagnostics in diseases like cancer and neurological disorders.

13 Mar 2015

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

13 Mar 2015

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine's first launch of ENDOCUFF VISION will take place in the UK Q2 2015.

12 Mar 2015

Single-site laparoscopic surgery effective for colorectal cancer

Colorectal cancer may be highly preventable, yet it is second only to lung cancer in the number of lives it takes nationwide each year.

6 Mar 2015

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

Novogen today announces that Professor Gil Mor MD PhD from Yale Medical School will be presenting pre-clinical data on the lead candidate product, Cantrixil, at two upcoming conferences.

6 Mar 2015

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot study to assess the feasibility of VolitionRx's proprietary NuQ assays in detecting prostate cancer.

5 Mar 2015

CCO wants men and women in Ontario to get screened for colorectal cancer

March is Colorectal Cancer Awareness Month, and Cancer Care Ontario wants men and women to start thinking about getting screened.

4 Mar 2015

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH, a large French study of patients with advanced, inoperable primary liver cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding its 400-patient target, according to its principal investigator, Professor Valérie Vilgrain MD, PhD, Department of Radiology, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP) and Université Paris Diderot, Sorbonne Paris Cité, France.

4 Mar 2015

Key questions about colorectal cancer answered

Colorectal cancer is the fourth most common cancer in the U.S., with more than 136,000 new patients diagnosed last year. But thanks to increased awareness about screenings, the death rate from colorectal cancer has been dropping for more than 20 years.

4 Mar 2015

Study findings raise questions about additional value of cancer care in the U.S.

Despite sharp increases in spending on cancer treatment, cancer mortality rates in the United States have decreased only modestly since 1970, Samir Soneji, PhD of Dartmouth's Norris Cotton Cancer Center and The Dartmouth Institute for Health Policy & Clinical Practice has found.

3 Mar 2015

EMA extends approval of Vectibix plus FOLFIRI as first-line treatment for wild-type RAS mCRC

Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab) to include combination with FOLFIRI (an irinotecan-based chemotherapy) as first-line treatment in adult patients with wild-type RAS metastatic colorectal cancer (mCRC).

3 Mar 2015

Cancer Care Ontario raises awareness about colorectal cancer

March is Colorectal Cancer Awareness Month and Cancer Care Ontario (CCO) is on a mission to raise awareness about an organ that doesn't get the attention it deserves.

2 Mar 2015

Taiho announces submission of TAS-102 MAA to EMA for treatment of mCRC

Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).

2 Mar 2015

Insurance status linked to patient safety, quality of care for patients with brain tumors

Patients that are on Medicaid or uninsured have higher rates of reportable patient safety and quality of care issues during hospitalization for brain tumors, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

28 Feb 2015

NYU Langone reminds people about importance of screening and preventing colorectal cancer

According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."

28 Feb 2015

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

New diagnostic method replaces surgery for bowel tumor assessment

Genetic markers may help decide who benefits from aspirin, NSAIDs in lowering risk of colorectal cancer

Penn researchers find evidence of new culprit in colon cancer

Parenchymal preservation surgery linked to lower mortality, complication rates in cancer patients

TNMNews examines how cannabis laws impact students, families

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

ERC project aims to identify new treatments for prostate cancer

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Single-site laparoscopic surgery effective for colorectal cancer

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

CCO wants men and women in Ontario to get screened for colorectal cancer

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

Key questions about colorectal cancer answered

Study findings raise questions about additional value of cancer care in the U.S.

EMA extends approval of Vectibix plus FOLFIRI as first-line treatment for wild-type RAS mCRC

Cancer Care Ontario raises awareness about colorectal cancer

Taiho announces submission of TAS-102 MAA to EMA for treatment of mCRC

Insurance status linked to patient safety, quality of care for patients with brain tumors

NYU Langone reminds people about importance of screening and preventing colorectal cancer

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in